Edwards beats Medtronic in head-to-head TAVI study
This article was originally published in Clinica
Executive Summary
Arch transcathether aortic valve implantation (TAVI) rivals Edwards Lifesciences and Medtronic have gone up against each other again, this time in the clinic. And while Edwards’ Sapien XT came out on top in comparison to Medtronic’s rival device, CoreValve, Jefferies analyst Raj Denhoy warned investors not to get overexcited.